0LDR.L

Teladoc Health, Inc.
LSEUSDEQUITY DELAYED
Last price
6.49
▼ 0.00 (0.01%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
6.56
Prev close
6.49
Day high
6.66
Day low
6.36
Volume
18.41K
Market cap
P/E (TTM)
52W range
6.36 – 30.38

Day trading desk

Current session · delayed
Gap from prior close
VWAP
6.40
+1.34% from price
Relative volume
0.94×
Normal
Session range
4.55%
6.37 – 6.66
Position in range
41%
Mid range
ATR (14D)
Daily true range
Prior day high
PDH
Prior day low
PDL
Bid / ask spread
Quote not published
Session volume
18.36K
Avg 19.44K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on 0LDR.L open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
1.27M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jul 6, 26
BLISS KELLY
Officer
SELL 2.50K $23.75K Direct
Jul 2, 26
CATAPANO JOSEPH RONALD
Officer
SELL 653 $5.94K Direct
Jul 1, 26
BLISS KELLY
Officer
SELL 2.50K $22.50K Direct
Jul 1, 26
CATAPANO JOSEPH RONALD
Officer
2.08K Direct
Jun 29, 26
BLISS KELLY
Officer
SELL 2.50K $21.25K Direct
Jun 11, 26
DIVITA CHARLESIII
Chief Executive Officer
SELL 18.07K $125.47K Direct
Jun 10, 26
DIVITA CHARLESIII
Chief Executive Officer
42.80K Direct
Jun 3, 26
RODRIGUES FERNANDO MADEIRA
Officer
SELL 9.57K $70.83K Direct
Jun 2, 26
CATAPANO JOSEPH RONALD
Officer
SELL 284 $2.17K Direct
Jun 2, 26
DIVITA CHARLESIII
Chief Executive Officer
SELL 19.13K $145.92K Direct
Jun 2, 26
NUENO CARLOS PLANA
Officer
SELL 6.20K $47.26K Direct
Jun 2, 26
BLISS KELLY
Officer
SELL 7.68K $58.57K Direct
Jun 2, 26
RODRIGUES FERNANDO MADEIRA
Officer
SELL 5.68K $43.30K Direct
Jun 2, 26
VANDERVOORT ADAM C
Officer
SELL 7.91K $60.30K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
BLISS KELLY
Officer 84.88K Sale
DIVITA CHARLESIII
Chief Executive Officer 414.62K Sale
JACOBSON CATHERINE
Director 66.85K Conversion of Exercise of derivative security
MURTHY MALA
Chief Financial Officer 142.38K Sale
NANIS NIKOLAOS P
Chief Technology Officer 75.41K Sale
NUENO CARLOS PLANA
Officer 57.67K Sale
SHEDLARZ DAVID L
Director 61.27K Conversion of Exercise of derivative security
SNOW DAVID B JR
Director 165.03K Conversion of Exercise of derivative security
VANDERVOORT ADAM C
Officer 110.26K Sale
WATERS MICHAEL WILLEM
Chief Operating Officer 78.31K Sale

Fundamentals

TTM · reported
Market cap
Enterprise value$1.42B
Revenue (TTM)$2.49B
Gross profit$1.72B
EBITDA$64.56M
Net income$-177.40M
EPS (TTM)$-43.42
Free cash flow$191.04M
Total cash$774.35M
Total debt$1.04B
Book value / share$7.21
Shares outstanding70.11M
Float180.51M
Short % of float
Dividend yield
Beta (5Y)2.13

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book0.88
EV / revenue0.57
EV / EBITDA21.95
Gross margin68.97%
Operating margin-5.68%
Profit margin-7.13%
Return on equity-12.98%
Return on assets-3.22%
Debt / equity79.09
Current ratio0.83
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $592.72M -5.4%
Next quarter $601.99M -6.3%
Current year $2.42B -4.4%
Next year $2.39B -1.1%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders0.70%
Held by institutions87.15%
Institutions holding470
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
SMA 20
SMA 50
SMA 100
SMA 200
EMA 12
EMA 26
EMA 50
RSI (14)
MACD (12,26,9)
Hist —
ATR (14)
Realised vol 30D
Annualised
Bollinger upper
20, 2σ
Bollinger lower
20, 2σ
50 / 200 cross
Trend bias

Options chain

Account required
ExpirySpot 6.49
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
Correlation to SPY
Realised vol 30D
Annualised
Market vol 1Y
SPY, annualised
Max drawdown 1Y
Peak to trough
Max drawdown 5Y
Peak to trough
ATR 14
Average true range
Beta (reported)
2.13
5Y monthly, from filing

Rating changes

338 on file
DateFirm ActionFromTo
Aug 3, 26 Citigroup MAINTAINED Neutral Neutral
Jul 30, 26 Canaccord Genuity MAINTAINED Buy Buy
Jul 30, 26 Evercore ISI Group MAINTAINED In-Line In-Line
Jul 21, 26 Canaccord Genuity MAINTAINED Buy Buy
Jul 7, 26 B of A Securities MAINTAINED Buy Buy
May 5, 26 Citigroup MAINTAINED Neutral Neutral
Apr 8, 26 Evercore ISI Group MAINTAINED In-Line In-Line
Mar 26, 26 Barclays MAINTAINED Equal-Weight Equal-Weight
Mar 13, 26 JP Morgan MAINTAINED Neutral Neutral
Mar 10, 26 Deutsche Bank UPGRADE Hold Buy
Mar 3, 26 Citigroup MAINTAINED Neutral Neutral
Mar 3, 26 Oppenheimer MAINTAINED Outperform Outperform

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.